Escherichia coli O104:H4 outbreak in Germany

New England Journal of Medicine

Volumn 366, Issue 8, 2012, Pages 766-767

  Trachtman, Howard ^a  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT;

BLOODY DIARRHEA; DISEASE ASSOCIATION; ENTERITIS; EPIDEMIC; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTION; GASTROENTERITIS; GERMANY; HEMOLYTIC UREMIC SYNDROME; HUMAN; INFECTION RISK; LETTER; NONHUMAN; PATHOGENICITY; PRIORITY JOURNAL;

EID: 84857409345     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc1200169     Document Type: Letter

References (5)

1. Frank C, Werber D, Cramer JP, et al. Epidemic profile of Shiga-toxin-producing Escherichia coli O104:H4 outbreak in Germany. N Engl J Med 2011;365:1771-80.
2. Trachtman H, Cnaan A, Christen E, et al. Effect of an oral Shiga toxin-binding agent on diarrhea-associated hemolytic uremic syndrome in children: a randomized controlled trial. JAMA 2003;290:1337-44. (Pubitemid 37442630)
3. Wong CS, Jelacic S, Habeeb RL, Watkins SL, Tarr PI. The risk of hemolytic-uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 infections. N Engl J Med 2000;342:1930-6. (Pubitemid 30419087)
4. Pavia AT, Nichols CR, Green DP, et al. Hemolytic-uremic syndrome during an outbreak of Escherichia coli O157:H7 infections in institutions for mentally retarded persons: clinical and epidemiological observations. J Pediatr 1990;116:544-51. (Pubitemid 20124149)
5. Zhang Q, Donohue-Rolfe A, Krautz-Peterson G, et al. Gnotobiotic piglet infection model for evaluating the safe use of antibiotics against Escherichia coli O157:H7 infection. J Infect Dis 2009;199:486-93.